---
figid: PMC5715262__CAS-108-2319-g003
figtitle: Molecular pathways around CIC in cancer
organisms:
- Homo sapiens
- Mus musculus
- Drosophila melanogaster
pmcid: PMC5715262
filename: CAS-108-2319-g003.jpg
figlink: /pmc/articles/PMC5715262/figure/cas13413-fig-0003/
number: F3
caption: Molecular pathways around CIC in cancer. (a) Upregulation of downstream genes
  are achieved at the physiological level (top), CIC mutations (middle), or CIC fusion
  (bottom) at various levels. (b) Relationship between inhibitory drugs in the receptor
  tyrosine kinase (RTK)/RAS/MAPK pathway and the ataxin 1 like (ATXN1L)/CIC axis.
  Mutations within the pathway downregulate CIC (i), and tyrosine kinase inhibitors
  (TKI) and trametinib inhibit the downregulation (ii). When expression of ATXN1L
  or CIC is significantly reduced, the effects are cancelled (iii).
papertitle: 'A double‚Äêedged sword: The world according to Capicua in cancer.'
reftext: Miwa Tanaka, et al. Cancer Sci. 2017 Dec;108(12):2319-2325.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9431458
figid_alias: PMC5715262__F3
figtype: Figure
organisms_ner:
- Homo sapiens
- Mus musculus
- Drosophila melanogaster
redirect_from: /figures/PMC5715262__F3
ndex: e7c765bd-df00-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5715262__CAS-108-2319-g003.html
  '@type': Dataset
  description: Molecular pathways around CIC in cancer. (a) Upregulation of downstream
    genes are achieved at the physiological level (top), CIC mutations (middle), or
    CIC fusion (bottom) at various levels. (b) Relationship between inhibitory drugs
    in the receptor tyrosine kinase (RTK)/RAS/MAPK pathway and the ataxin 1 like (ATXN1L)/CIC
    axis. Mutations within the pathway downregulate CIC (i), and tyrosine kinase inhibitors
    (TKI) and trametinib inhibit the downregulation (ii). When expression of ATXN1L
    or CIC is significantly reduced, the effects are cancelled (iii).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - KRAS
  - HRAS
  - NRAS
  - MAP2K1
  - MAP2K2
  - RPS6KA1
  - RPS6KA2
  - RPS6KA3
  - RPS6KA4
  - RPS6KA5
  - RPS6KA6
  - EPHB2
  - MAPK1
  - MAPK3
  - YWHAQ
  - CIC
  - SLC25A1
  - ETV4
  - ETV1
  - CCND1
  - CCND2
  - MMP1
  - MMP2
  - MMP3
  - MMP7
  - MMP8
  - MMP9
  - MMP10
  - MMP11
  - MMP12
  - MMP13
  - MMP14
  - MMP15
  - MMP16
  - MMP17
  - MMP19
  - MMP20
  - MMP21
  - MMP23B
  - MMP24
  - MMP25
  - MMP26
  - MMP27
  - MMP28
  - DUX4
  - DUX4L1
  - DUX4L2
  - MAP2K7
  - ATXN10
  - ATXN1L
  - ras
  - Hras
  - Kras
  - Rem1
  - Map2k1
  - Map2k2
  - Rps6ka1
  - Rps6ka2
  - Ephb2
  - Mapk1
  - Sfn
  - Cic
  - Etv4
  - Etv1
  - Ccnd1
  - Ccnd2
  - Dux
  - Mdk
  - Atxn10
  - Atxn1l
  - Ras64B
  - Ras85D
  - Dsor1
  - Erk7
  - rl
  - 14-3-3zeta
  - 14-3-3epsilon
  - cic
  - Mmp1
  - bi
  - Tie
  - InR
  - Mtk
  - CG4975
  - mid
  - 'On'
  - 'Off'
  - trametinib
---
